Abstract
Endothelial cells are a target of halogenated aromatic hydrocarbon toxicity following aryl hydrocarbon receptor (AHR) activation. Further, evidence suggests that AHR has a physiological function in endothelial cells in the absence of exogenous ligands. Understanding these “normal” functions of AHR may help to reveal the mechanisms that contribute to the toxicity of xenobiotic ligands. Thus, this study focused on the crosstalk between hypoxia and AHR in the absence of exogenous ligands. Constitutive CYP1A1 mRNA was measured by real time PCR in human pulmonary microvascular endothelial cells exposed to hypoxia (1 or 2.5% O2), 25 nM AHR siRNA, 25 nM hypoxia-inducible factor (HIF)-2α siRNA, or their combinations. Hypoxia significantly induced known hypoxia-regulated genes, and this induction was highly attenuated by HIF-2α siRNA, suggesting that HIF-2α is a primary mediator of hypoxic responses in these cells. Hypoxia also significantly reduced CYP1A1 mRNA and this reduction was also attenuated by HIF-2α siRNA. As expected, AHR siRNA significantly reduced constitutive CYP1A1 mRNA. While the combination of hypoxia plus AHR siRNA reduced CYP1A1 mRNA more than either treatment alone, the reduction was less than additive, suggesting that hypoxia and AHR deficiency may share a common pathway in reducing CYP1A1 expression. Finally, hypoxia significantly reduced AHR mRNA and this reduction was completely prevented by HIF-2α siRNA. In conclusion, constitutive CYP1A1 mRNA expression is dependent on AHR and is reduced by hypoxia via a HIF-2α-dependent mechanism, which may be mediated by a HIF-2α-dependent reduction of AHR expression.
Similar content being viewed by others
References
Chen, H. S., & Perdew, G. H. (1994). Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. The Journal of Biological Chemistry, 269, 27554–27558.
Eskin, S. G., Turner, N. A., & McIntire, L. V. (2004). Endothelial cell cytochrome P450 1A1 and 1B1: Up-regulation by shear stress. Endothelium, 11, 1–10.
McMillan, B. J., & Bradfield, C. A. (2007). The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America, 104, 1412–1417.
Sadek, C. M., & Allen-Hoffmann, B. L. (1994). Suspension-mediated induction of Hepa 1c1c7 Cyp1a-1 expression is dependent on the Ah receptor signal transduction pathway. The Journal of Biological Chemistry, 269, 31505–31509.
Sadek, C. M., & Allen-Hoffmann, B. L. (1994). Cytochrome P450IA1 is rapidly induced in normal human keratinocytes in the absence of xenobiotics. The Journal of Biological Chemistry, 269, 16067–16074.
Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., & Bradfield, C. A. (2000). Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 10442–10447.
Lund, A. K., Goens, M. B., Kanagy, N. L., & Walker, M. K. (2003). Cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice is correlated with elevated angiotensin II, endothelin-1 and mean arterial blood pressure. Toxicology and Applied Pharmacology, 193, 177–187.
Thackaberry, E. A., Gabaldon, D., Walker, M. K., & Smith, S. M. (2002). Aryl hydrocarbon receptor null mice exhibit cardiac hypertrophy and increased cardiac hypoxia-inducible factor 1-α in the absence of cardiac hypoxia. Cardiovascular Toxicology, 4, 263–273.
Vasquez, A., Atallah-Yunes, N., Smith, F. C., You, X., Chase, S. E., Silverstone, A. E., & Vikstrom, K. L. (2003). A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovascular Toxicology, 3, 153–163.
Fernandez-Salguero, P. M., Ward, J. M., Sundberg, J. P., & Gonzalez, F. J. (1997). Lesions of aryl-hydrocarbon receptor-deficient mice. Veterinary Pathology, 34, 605–614.
Wenger, R. H. (2002). Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB Journal, 16, 1151–1162.
Kewley, R. J., Whitelaw, M. L., & Chapman-Smith, A. (2004). The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. The International Journal of Biochemistry & Cell Biology, 36, 189–204.
Chan, W. K., Yao, G., Gu, Y. Z., & Bradfield, C. A. (1999). Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. The Journal of Biological Chemistry, 274, 12115–12123.
Gradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., Whitelaw, M. L., Toftgard, R, Tora, L., Gassmann, M., & Poellinger, L. (1996). Functional interference between hypoxia and dioxin signal transduction pathways: Competition for recruitment of the Arnt transcription factor. Molecular and Cellular Biology, 16, 5221–5231.
Pollenz, R. S., Davarinos, N. A., & Shearer, T. P. (1999). Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. Molecular Pharmacology, 56, 1127–1137.
Nie, M., Blankenship, A. L., & Giesy, J. P. (2001). Interactions between aryl hydrocarbon receptor (AhR) and hypoxia signaling pathways. Environmental Toxicology and Pharmacology, 10, 17–27.
Roblin, S., Okey, A. B., & Harper, P. A. (2004). AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells. Biochemical and Biophysical Research Communications, 317, 142–148.
Chiaro, C. R., Patel, R. D., Marcus, C. B., & Perdew, G. H. (2007). Evidence for an Ah receptor-mediated cytochrome P450 auto-regulatory pathway. Molecular Pharmacology. Published on-line: August 24, 2007; doi:10.1124/mol.107.038968.
Fradette, C., & Du, S. P. (2004). Effect of hypoxia on cytochrome P450 activity and expression. Current Drug Metabolism, 5, 257–271.
Elvidge, G. P., Glenny, L., Appelhoff, R. J., Ratcliffe, P. J., Ragoussis, J., & Gleadle, J. M. (2006). Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: The role of HIF-1alpha, HIF-2alpha, and other pathways. The Journal of Biological Chemistry, 281, 15215–15226.
Song, J., Claget-Dame, M., Peterson, R. E., Hahn, M. E., Westler, W. M., Sicinski, R. R., & DeLuca, H. (2002). A ligand for the aryl hydrocarbon receptor isolated from lung. Proceedings of the National Academy of Sciences of the United States of America, 99, 14694–14699.
Hu, C. J., Sataur, A., Wang, L., Chen, H., & Simon, M. C. (2007). The N-terminal transactivation domain confers target gene specificity of hypoxia inducible factors HIF-1{alpha} and HIF-2{alpha}. Molecular Pharmacology Cell Published on-line: September 5, 2007; doi:10.1091/mbc.E06–05–0419 .
Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003). Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Molecular and Cellular Biology, 23, 9361–9374.
Stegeman, J. J., Hahn, M. E., Weisbrod, R., Woodin, B. R., Joy, J. S., Najibi, S., & Cohen, R. A. (1995). Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells. Molecular Pharmacology, 47, 296–306.
Ma, Q., Baldwin, K. T., Renzelli, A. J., McDaniel, A., & Dong, L. (2001). TCDD-inducible poly(ADP-ribose) polymerase: A novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochemical and Biophysical Research Communications, 289, 499–506.
Couroucli, X. I., Welty, S. E., Geske, R. S., & Moorthy, B. (2002). Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: Implications for hyperoxic lung injury. Molecular Pharmacology, 61, 507–515.
McMillan, B. J., & Bradfield, C. A. (2007). The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems. Molecular Pharmacology, 27, 487–498.
Abdelrahim, M., Smith, R. III, & Safe, S. (2003). Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Molecular Pharmacology, 63, 1373–1381.
Akahoshi, E., Yoshimura, S., & Ishihara-Sugano, M. (2006). Over-expression of AhR (aryl hydrocarbon receptor) induces neural differentiation of Neuro2a cells: Neurotoxicology study. Environmental Health, 5, 24.
Fradette, C., Bleau, A. M., Pichette, V., Chauret, N., & Du, S. P. (2002). Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators. British Journal of Clinical Pharmacology, 137, 881–891.
Carriere, V., Dussaulx, E., Rousset, M., Zweibaum, A., & Cambier, D. (1998). Decreased expression of gamma-glutamyltranspeptidase in the intestinal cell line Caco-2 by inducers of cytochrome P450 1A1. Biochemical Pharmacology, 56, 817–823.
Fradette, C., Batonga, J., Teng, S., Piquette-Miller, M., & Du, S. P. (2007). Animal models of acute moderate hypoxia are associated with a down-regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and up-regulation of CYP3A6 and P-glycoprotein in liver. Drug Metabolism and Disposition, 35, 765–771.
Jiang, W., Welty, S. E., Couroucli, X. I., Barrios, R., Kondraganti, S. R., Muthiah, K., Yu, L., Avery, S. E., & Moorthy, B. (2004). Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. The Journal of Pharmacology and Experimental Therapeutics, 310, 512–519.
Moorthy, B., Parker, K. M., Smith, C. V., Bend, J. R., & Welty, S. E. (2000). Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole. The Journal of Pharmacology and Experimental Therapeutics, 292, 553–560.
Brusselmans, K., Compernolle, V., Tjwa, M., Wiesener, M. S., Maxwell, P. H., Collen, D., & Carmeliet, P. (2003). Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. The Journal of Clinical Investigation, 111, 1519–1527.
Yu, A. Y., Shimoda, L. A., Iyer, N. V., Huso, D. L., Sun, X., McWilliams, R., Beaty, T., Sham, J. S. K., Wiener, C. M. et al. (1999). Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. The Journal of Clinical Investigation, 103, 691–696.
Lee, K., Burgoon, L. D., Lamb, L., Dere, E., Zacharewski, T. R., Hogenesch, J. B., & LaPres, J. J. (2006). Identification and characterization of genes susceptible to transcriptional cross-talk between the hypoxia and dioxin signaling cascades. Chemical Research in Toxicology, 19, 1284–1293.
Allen, J. W., Johnson, R. S., & Bhatia, S. N. (2005). Hypoxic inhibition of 3-methylcholanthrene-induced CYP1A1 expression is independent of HIF-1alpha. Toxicology Letters, 155, 151–159.
Acknowledgments
This work was supported by grants from the American Heart Association (055028Z) and NIH (HL078914) to M.K.W. We thank Ed Bedrick for assistance with statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, N., Walker, M.K. Crosstalk Between the Aryl Hydrocarbon Receptor and Hypoxia on the Constitutive Expression of Cytochrome P4501A1 mRNA. Cardiovasc Toxicol 7, 282–290 (2007). https://doi.org/10.1007/s12012-007-9007-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-007-9007-6